• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗抑郁药:当前的作用机制概念

Antidepressants: current concepts of mode of action.

作者信息

Cowen P J

机构信息

MRC Unit of Clinical Pharmacology, Littlemore Hospital, Oxford, England.

出版信息

Int Clin Psychopharmacol. 1990 Jul;5 Suppl 3:45-55.

PMID:2172364
Abstract

Repeated administration of antidepressant drugs to rodents produces adaptive changes in noradrenaline and 5-hydroxytryptamine pathways in the brain. A decrease in cortical beta-adrenoceptor binding is seen following most antidepressant treatments and is thought by some to be of importance in the therapeutic action of antidepressants; however, it seems equally plausible that this change simply reflects a homeostatic response to increased noradrenergic transmission. Another effect common to many different antidepressant treatments is an increase in neurotransmission through post-synaptic 5-HT1 receptors in some brain regions. 5-HT neuroendocrine studies suggest that this change also occurs in the human brain. Further investigations are required to assess whether alterations in 5-HT neurotransmissions are important in the therapeutic action of antidepressant treatment.

摘要

对啮齿动物反复给予抗抑郁药物会使大脑中的去甲肾上腺素和5-羟色胺途径产生适应性变化。大多数抗抑郁治疗后会出现皮质β-肾上腺素能受体结合减少的情况,一些人认为这在抗抑郁药的治疗作用中具有重要意义;然而,这种变化仅仅反映了对去甲肾上腺素能传递增加的一种稳态反应,这似乎同样合理。许多不同抗抑郁治疗的另一个共同作用是,某些脑区通过突触后5-HT1受体的神经传递增加。5-羟色胺神经内分泌研究表明,这种变化在人类大脑中也会发生。需要进一步研究来评估5-羟色胺神经传递的改变在抗抑郁治疗的治疗作用中是否重要。

相似文献

1
Antidepressants: current concepts of mode of action.抗抑郁药:当前的作用机制概念
Int Clin Psychopharmacol. 1990 Jul;5 Suppl 3:45-55.
2
Molecular and cellular mechanisms of antidepressant drugs.抗抑郁药物的分子和细胞机制
Depress Anxiety. 1996;4(4):153-9. doi: 10.1002/(SICI)1520-6394(1996)4:4<153::AID-DA1>3.0.CO;2-G.
3
[Antidepressant drugs and central monoaminergic receptors].[抗抑郁药物与中枢单胺能受体]
Yakubutsu Seishin Kodo. 1985 Dec;5(4):303-19.
4
Antidepressants. Current concepts of mode of action.抗抑郁药。作用机制的当前概念。
Encephale. 1991 May-Jun;17 Spec No 1:127-31.
5
Receptor alterations associated with serotonergic agents: an autoradiographic analysis.与血清素能药物相关的受体改变:放射自显影分析
J Clin Psychiatry. 1987 Mar;48 Suppl:19-25.
6
[Mechanism of action of antidepressants and therapeutic perspectives].[抗抑郁药的作用机制及治疗前景]
Therapie. 2002 Jul-Aug;57(4):385-96.
7
Antidepressant treatment and side effect considerations.
J Clin Psychiatry. 1991 May;52 Suppl:4-13.
8
5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?5-羟色胺1A受体与药物治疗。血清素受体下调与抗抑郁药物的作用机制有关吗?
Psychopharmacol Bull. 1994;30(1):39-43.
9
Effect of pharmacologic treatments on the sleep of depressed patients.药物治疗对抑郁症患者睡眠的影响。
Biol Psychiatry. 1995 Jan 15;37(2):85-98. doi: 10.1016/0006-3223(94)00135-P.
10
Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.地昔帕明及其他抗抑郁药物对神经递质受体的调节:抗抑郁作用的神经递质受体假说
J Clin Psychiatry. 1984 Oct;45(10 Pt 2):37-45.

引用本文的文献

1
Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance.血清素再摄取抑制剂的药理学差异及可能的临床相关性。
Drugs. 1992;43 Suppl 2:3-9; discussion 9-10. doi: 10.2165/00003495-199200432-00003.